Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

GoHealth (GOCO) EBITDA (2019 - 2025)

Historic EBITDA for GoHealth (GOCO) over the last 7 years, with Q3 2025 value amounting to -$287.9 million.

  • GoHealth's EBITDA fell 57472.11% to -$287.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$300.4 million, marking a year-over-year decrease of 31570.99%. This contributed to the annual value of -$7.0 million for FY2024, which is 9137.25% up from last year.
  • As of Q3 2025, GoHealth's EBITDA stood at -$287.9 million, which was down 57472.11% from -$99.4 million recorded in Q2 2025.
  • In the past 5 years, GoHealth's EBITDA ranged from a high of $80.3 million in Q4 2024 and a low of -$423.2 million during Q4 2021
  • In the last 5 years, GoHealth's EBITDA had a median value of -$40.6 million in 2024 and averaged -$67.2 million.
  • Per our database at Business Quant, GoHealth's EBITDA plummeted by 541628.21% in 2021 and then soared by 43298.14% in 2024.
  • Quarter analysis of 5 years shows GoHealth's EBITDA stood at -$423.2 million in 2021, then surged by 68.53% to -$133.2 million in 2022, then soared by 111.31% to $15.1 million in 2023, then surged by 432.98% to $80.3 million in 2024, then crashed by 458.7% to -$287.9 million in 2025.
  • Its EBITDA was -$287.9 million in Q3 2025, compared to -$99.4 million in Q2 2025 and $6.7 million in Q1 2025.